Product
copanlisib
1 clinical trial
1 indication
Indication
Bladder CancerClinical trial
A Phase II Trial With Copanlisib Plus Avelumab as a Maintenance Therapy for Metastatic Bladder Cancer After Platinum-based ChemotherapyStatus: Not yet recruiting, Estimated PCD: 2028-06-30